A similar reduction in the prevalence of patients meeting the criteria for metabolic syndrome was observed despite patients on varying background medications across the T2D continuum
The discontinuation was driven by (Bergam, 2025) (Figure 2): the availability of newer, safer & more accurate alternative testing for MG including electrophysiological & antibody tests, as well as safety concerns (bradycardia & respiratory complications) limited diagnostic reliability (with both false-positive and false-negative results) The decision to remove edrophonium as an available (alternative) diagnostic test has been challenged (Keritam et al, 2026)
A21174, GeneArt CRISPR Nuclease Vector Kit)
Bodybuilders covet its power to enhance physical strength and overall well-being
This is especially true of older people and post-menopausal women who are already at high risk for this condition
For example, patients who are being prescribed GLP-1s are more likely to get coverage if they also have preexisting conditions such as type 2 diabetes, hypertension, cardiovascular disease, and the like